Latest: How AstraZeneca Built Constraint-Based Planning With OMP

Maintaining exceptional service levels to ensure quality patient care is critical to AstraZeneca, a biopharmaceutical company. But for years, its exceptional service levels came at a cost for the company in the form of elevated inventory levels and planning decisions made with limited end-to-end visibility into its supply chain, which impacted agility and growth.